Northern Trust’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.7M | Buy |
|
|||||
|
2022
Q3 | $5.4M | Sell |
|
|||||
|
2022
Q2 | $6.93M | Buy |
|
|||||
|
2022
Q1 | $6.56M | Sell |
|
|||||
|
2021
Q4 | $13.7M | Buy |
|
|||||
|
2021
Q3 | $22.3M | Buy |
|
|||||
|
2021
Q2 | $27.7M | Buy |
|
|||||
|
2021
Q1 | $22.7M | Sell |
|
|||||
|
2020
Q4 | $19.8M | Buy |
|
|||||
|
2020
Q3 | $29.6M | Buy |
|
|||||
|
2020
Q2 | $14.4M | Buy |
|
|||||
|
2020
Q1 | $2.99M | Buy |
|
|||||
|
2019
Q4 | $5.35M | Buy |
|
|||||
|
2019
Q3 | $3.2M | Buy |
|
|||||
|
2019
Q2 | $3.61M | Buy |
|
|||||
|
2019
Q1 | $6.34M | Buy |
|
|||||
|
2018
Q4 | $3.02M | Sell |
|
|||||
|
2018
Q3 | $5.67M | Buy |
|
|||||
|
2018
Q2 | $7.23M | Buy |
|
|||||
|
2018
Q1 | $804K | Buy |
|
|||||
|
2017
Q4 | $513K | Sell |
|
|||||
|
2017
Q3 | $297K | Sell |
|
|||||
|
2017
Q2 | $353K | Sell |
|
|||||
|
2017
Q1 | $1.37M | Sell |
|
|||||
|
2016
Q4 | $1.85M | Sell |
|
|||||
|
2016
Q3 | $2.92M | Buy |
|
|||||
|
2016
Q2 | $2.05M | Buy |
|
|||||
|
2016
Q1 | $1.76M | Buy |
|
|||||
|
2015
Q4 | $2.83M | Buy |
|
|||||
|
2015
Q3 | $2.63M | Buy |
|
|||||
|
2015
Q2 | $1.5M | Buy |
|
|||||
|
2015
Q1 | $493K | Buy |
|
|||||
|
2014
Q4 | $350K | Sell |
|
|||||
|
2014
Q3 | $171K | Sell |
|
|||||
|
2014
Q2 | $256K | Buy |
|
|||||
|
2014
Q1 | $238K | Buy |
|